Study ID and Year | Intervention | Control | ||||||||
Faye et al. (2010) | AS + MQ (FC = ?; PC = 99% D2) | AL (FC = ?; PC = 99% D2) | ||||||||
Kapisi et al. (2015) | No Chemoprevention | SP (FC ≥ 96%; PC = 99% D3) | TS (FC ≥ 96%; PC = 99% D3) | DHAPQ (FC ≥ 97%; PC = 99% D3) | ||||||
Maiga et al. (2015) | SP+AS (FC = 98.3; PC = ? D3) | SP+AQ (FC = 97.4%; PC = ? D3) | SP (FC = 94.1%; PC = ? D3) | |||||||
Nambozi et al. (2011) | DHAPQ (FC ≥ 97%; PC = 96.9% D3) | AL (FC = ˃97%; PC = 81.1% D3) | ||||||||
Schramm et al. (2013) | AS + AQ (FC = 100% D2; PC = 99.3% D28) | AL (FC = 100% D1; PC = 97.7% D28) | ||||||||
The 4ABC study Group (2011) | AS + AQ (FC = 95% D3; PC = 96.95% D3) | DHAPQ (FC = 95% D3; PC = 97.45% D3) | AL (FC = 95% D3; PC = 94.95% D3) | CD + A (FC = 95% D3; PC = ? D3) | ||||||
Whegang et al. (2010) | AQ(FC ≤ 90% D3; PC = 90% D 3) | AS + AQ (FC ≥ 90% D3; PC = 90% D3) | SP (FC ≥ 90% D3; PC = 90% D3) | SP+AQ (FC ≥ 90% D3; PC = 71.6% D3) | CD+A (FC ≥ 90% D3; PC = 95% D3) | AS + MQ (FC ≥ 90% D3; PC = 95.1% D3) | AL (FC ≥ 90% D3; PC = 98% D3) | DHAPQ (FC ≥ 90% D3; PC = 99% D3) | ||
Yeka et al. (2013) | Q (FC = ? D3; PC = 100% D3) | AL (FC = ? D3; PC = 100% D3) | DHAPQ (FC = ? D3; PC = 100% D3) | |||||||